137 related articles for article (PubMed ID: 19954178)
61. Haptenation of sulfonamide reactive metabolites to cellular proteins.
Manchanda T; Hess D; Dale L; Ferguson SG; Rieder MJ
Mol Pharmacol; 2002 Nov; 62(5):1011-26. PubMed ID: 12391263
[TBL] [Abstract][Full Text] [Related]
62. Suppression of T-lymphocyte proliferation by sulphonamide hydroxylamines.
Rieder MJ; Sisson E; Bird IA; Almawi WY
Int J Immunopharmacol; 1992 Oct; 14(7):1175-80. PubMed ID: 1452402
[TBL] [Abstract][Full Text] [Related]
63. Cytotoxicity of sulfonamide reactive metabolites: apoptosis and selective toxicity of CD8(+) cells by the hydroxylamine of sulfamethoxazole.
Hess DA; Sisson ME; Suria H; Wijsman J; Puvanesasingham R; Madrenas J; Rieder MJ
FASEB J; 1999 Oct; 13(13):1688-98. PubMed ID: 10506572
[TBL] [Abstract][Full Text] [Related]
64. Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites.
Rieder MJ; Uetrecht J; Shear NH; Cannon M; Miller M; Spielberg SP
Ann Intern Med; 1989 Feb; 110(4):286-9. PubMed ID: 2913915
[TBL] [Abstract][Full Text] [Related]
65. Novel non-labile covalent binding of sulfamethoxazole reactive metabolites to cultured human lymphoid cells.
Summan M; Cribb AE
Chem Biol Interact; 2002 Nov; 142(1-2):155-73. PubMed ID: 12399161
[TBL] [Abstract][Full Text] [Related]
66. Cytotoxicity of oxidative metabolites of procainamide.
Rubin RL; Uetrecht JP; Jones JE
J Pharmacol Exp Ther; 1987 Sep; 242(3):833-41. PubMed ID: 3656116
[TBL] [Abstract][Full Text] [Related]
67. Enhanced antigenicity leads to altered immunogenicity in sulfamethoxazole-hypersensitive patients with cystic fibrosis.
Elsheikh A; Castrejon L; Lavergne SN; Whitaker P; Monshi M; Callan H; El-Ghaiesh S; Farrell J; Pichler WJ; Peckham D; Park BK; Naisbitt DJ
J Allergy Clin Immunol; 2011 Jun; 127(6):1543-51.e3. PubMed ID: 21354601
[TBL] [Abstract][Full Text] [Related]
68. Plasma ascorbate deficiency is associated with impaired reduction of sulfamethoxazole-nitroso in HIV infection.
Trepanier LA; Yoder AR; Bajad S; Beckwith MD; Bellehumeur JL; Graziano FM
J Acquir Immune Defic Syndr; 2004 Aug; 36(5):1041-50. PubMed ID: 15247557
[TBL] [Abstract][Full Text] [Related]
69. Nucleophile addition of reduced glutathione on 2-methyl-2-nitroso compound: a combined electron paramagnetic resonance spectroscopy and electrospray tandem mass spectrometry study.
Triquigneaux M; Tuccio B; Lauricella R; Charles L
J Am Soc Mass Spectrom; 2009 Nov; 20(11):2013-20. PubMed ID: 19744863
[TBL] [Abstract][Full Text] [Related]
70. Direct photolysis of human metabolites of the antibiotic sulfamethoxazole: evidence for abiotic back-transformation.
Bonvin F; Omlin J; Rutler R; Schweizer WB; Alaimo PJ; Strathmann TJ; McNeill K; Kohn T
Environ Sci Technol; 2013 Jul; 47(13):6746-55. PubMed ID: 23186099
[TBL] [Abstract][Full Text] [Related]
71. The effect of cimetidine on the formation of sulfamethoxazole hydroxylamine in patients with human immunodeficiency virus.
Lehmann DF; Newman N; Morse PD
J Clin Pharmacol; 1998 May; 38(5):463-6. PubMed ID: 9602961
[TBL] [Abstract][Full Text] [Related]
72. "Danger" conditions increase sulfamethoxazole-protein adduct formation in human antigen-presenting cells.
Lavergne SN; Wang H; Callan HE; Park BK; Naisbitt DJ
J Pharmacol Exp Ther; 2009 Nov; 331(2):372-81. PubMed ID: 19666748
[TBL] [Abstract][Full Text] [Related]
73. Detection of Hepatic Drug Metabolite-Specific T-Cell Responses Using a Human Hepatocyte, Immune Cell Coculture System.
Ali SE; Meng X; Kafu L; Hammond S; Zhao Q; Ogese M; Sison-Young R; Jones R; Chan B; Livoti L; Sun Y; Sun L; Liu H; Topping A; Goldring C; Zhang F; Naisbitt DJ
Chem Res Toxicol; 2023 Mar; 36(3):390-401. PubMed ID: 36812109
[TBL] [Abstract][Full Text] [Related]
74. Application of in Vitro T Cell Assay Using Human Leukocyte Antigen-Typed Healthy Donors for the Assessment of Drug Immunogenicity.
Usui T; Faulkner L; Farrell J; French NS; Alfirevic A; Pirmohamed M; Park BK; Naisbitt DJ
Chem Res Toxicol; 2018 Mar; 31(3):165-167. PubMed ID: 29436218
[TBL] [Abstract][Full Text] [Related]
75. Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity.
Hammond S; Olsson-Brown A; Grice S; Gibson A; Gardner J; Castrejón-Flores JL; Jolly C; Fisher BA; Steven N; Betts C; Pirmohamed M; Meng X; Naisbitt DJ
Toxicol Sci; 2022 Feb; 186(1):58-69. PubMed ID: 34850240
[TBL] [Abstract][Full Text] [Related]
76. Antigenicity of sulfanilamide and its metabolites using fluorescent-labelled compounds.
Eyanagi R; Toda A; Ishii Y; Saito H; Soeda S; Shimeno H; Shigematsu H
Xenobiotica; 2005 Sep; 35(9):911-25. PubMed ID: 16308284
[TBL] [Abstract][Full Text] [Related]
77. Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity.
Naisbitt DJ; Hough SJ; Gill HJ; Pirmohamed M; Kitteringham NR; Park BK
Br J Pharmacol; 1999 Mar; 126(6):1393-407. PubMed ID: 10217534
[TBL] [Abstract][Full Text] [Related]
78. Activation of T cells by carbamazepine and carbamazepine metabolites.
Wu Y; Sanderson JP; Farrell J; Drummond NS; Hanson A; Bowkett E; Berry N; Stachulski AV; Clarke SE; Pichler WJ; Pirmohamed M; Park BK; Naisbitt DJ
J Allergy Clin Immunol; 2006 Jul; 118(1):233-41. PubMed ID: 16815161
[TBL] [Abstract][Full Text] [Related]
79. Effect of lipopolysaccharide (LPS)-evoked host defense activation on hepatic microsomal formation and reduction of sulfamethoxazole hydroxylamine in the rat.
Cribb AE; McQuaid T; Renton KW
Biochem Pharmacol; 2001 Aug; 62(4):457-9. PubMed ID: 11448455
[TBL] [Abstract][Full Text] [Related]
80. A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions.
Reilly TP; Lash LH; Doll MA; Hein DW; Woster PM; Svensson CK
J Invest Dermatol; 2000 Jun; 114(6):1164-73. PubMed ID: 10844561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
